Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Head and Neck Neoplasms 7 Squamous Cell Carcinoma of Head and Neck 5 Oropharyngeal Neoplasms 3 Tongue Neoplasms 1 Thyroid Neoplasms 1 Radiation Injuries 1 Pain, Postoperative 1 Pain 1 Mucositis 1 Mouth Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma 1

Interventions

Magnetic Resonance Spectroscopy 17 Iodine-131 16 lenvatinib 13 trametinib 12 Thyrotropin Alfa 11 Sorafenib 11 pembrolizumab 10 dabrafenib 10 Paclitaxel 9 vandetanib 8 Thyroxine 8 Surgical Procedures, Operative 7 Sunitinib 7 selpercatinib 6 cabozantinib 6 Nivolumab 6 Fluorodeoxyglucose F18 6 Everolimus 6 pazopanib 5 Vemurafenib 5 Thyroidectomy 5 Specimen Handling 5 Saline Solution 5 Radiotherapy 5 Radiofrequency Ablation 5 Cyclophosphamide 5 Cisplatin 5 Biopsy 5 apatinib 4 anlotinib 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Thyroid Neoplasms × Neck Dissection × Clear all

NCT03570021 2026-03-06

ESTIMABL3

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Active not recruiting

Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡